Higher Sweetener Intake Tracked With Faster Cognitive Decline
A large Brazilian cohort has drawn a sharp line between frequent use of low- and no-calorie sweeteners and faster decline in memory and thinking skills. In a study published in Neurology, adults with the highest intake of common sugar substitutes experienced a 62% faster decline in overall cognitive performance than those with the lowest intake. The difference was measured over roughly eight years and translated to about 1.6 additional years of brain aging on cognitive testing scales.
The finding does not prove harm from these sweeteners, but it does force a harder look at a category of products many people treat as metabolically neutral. Diet sodas, flavored waters, energy drinks, yogurt, and low-calorie desserts often rely on these compounds to preserve sweetness without sugar. In this cohort, the pattern was not subtle: higher exposure tracked with worse performance on repeated assessments of memory, language, verbal fluency, working memory, and processing speed.
The study included 12,772 adults in Brazil, with a mean age of 52 years at baseline. Participants completed detailed dietary questionnaires and then returned for cognitive testing at the beginning, middle, and end of follow-up. Those in the lowest intake group averaged 20 mg/day of the sweeteners studied, while the highest intake group averaged 191 mg/day. For context, 191 milligrams of aspartame is roughly the amount found in one can of diet soda.
One sentence captures the core result: the highest sweetener consumers declined faster.
Six Sweeteners Carried the Signal, Tagatose Did Not
Researchers examined seven specific sweeteners: aspartame, saccharin, acesulfame-K, erythritol, xylitol, sorbitol, and tagatose. Six of the seven were associated with faster decline in overall cognitive performance, with the strongest signal appearing in memory. Those six were aspartame, saccharin, acesulfame-K, erythritol, sorbitol, and xylitol. Tagatose stood apart in this analysis, with no observed association with cognitive decline.
Sorbitol had the highest average intake in the cohort at 64 mg/day. As a sugar alcohol, it belongs to a class of sweeteners commonly used in processed foods and beverages. The presence of multiple sweeteners showing a similar association raises the possibility that the issue may not belong to a single molecule alone, but to a broader pattern of dietary exposure tied to ultra-processed, low-calorie products. Even so, this remains an observational dataset, and no one should read it as proof that any one sweetener directly injures the brain.
The study design matters here. Dietary exposure came from self-reported intake over the prior year, and cognitive performance was measured prospectively across time. That structure can reveal associations, but it cannot fully untangle whether sweeteners themselves drive the decline or whether they stand in for other lifestyle or metabolic factors that travel with them.
Diabetes and Midlife Appeared to Carry More of the Risk Signal
The association was not evenly distributed across the population. It was stronger among people with diabetes, a group that often turns to sugar substitutes in an effort to reduce sugar intake. The link also appeared more clearly in adults younger than 60, where higher sweetener consumption tracked with faster declines in verbal fluency and overall cognition. No similar association emerged in participants older than 60.
That age split may reflect differences in baseline vulnerability, competing health conditions, or the way early cognitive change is captured in midlife. It also fits a familiar clinical concern: metabolic disease may amplify susceptibility to vascular or inflammatory pathways that gradually affect the brain. Diabetes can accelerate microvascular injury, insulin dysregulation, and systemic inflammation, all of which are plausible contributors to cognitive decline. If sweetener exposure marks a dietary pattern built around ultraprocessed foods and metabolic risk, the brain may be picking up that broader burden rather than a single ingredient.
Another sentence stands on its own: diabetes strengthened the association.
What the Numbers Do and Do Not Mean at the Bedside
The reported 62% faster decline sounds dramatic, but the endpoint was cognitive test performance, not a direct biological measure of brain aging. The estimate of 1.6 additional years of cognitive aging is a useful way to express the magnitude of the difference, yet it remains an approximation derived from longitudinal testing rather than a literal clock of neuronal loss. The middle intake group also showed a measurable signal, with a 35% faster decline and an estimated 1.3 additional years of cognitive aging compared with the lowest group.
For clinicians, the practical issue is not panic over a single diet drink or a scoop of tabletop sweetener. It is the cumulative habit of using these products as a routine substitute across years, especially in patients already at elevated risk for cognitive impairment. A person with diabetes who reaches for sugar-free options may believe the brain is being protected simply because calories fall. This study suggests the long view may be more complicated.
That possibility deserves careful framing. No causal claim is justified, and no patient can be told from this study alone that sweeteners will cause memory loss. Still, repeated observational consistency across several compounds and several cognitive domains makes the question clinically relevant rather than theoretical.
Biological Questions That Remain Open
Several mechanisms could explain why this association appears at all. Sweeteners may alter vascular risk, inflammatory signaling, the gut microbiome, or metabolic regulation in ways that eventually affect cerebral function. Another possibility is confounding by diet quality: people relying heavily on artificially sweetened products may also consume more ultra-processed foods or have other health characteristics that are difficult to fully measure in an observational cohort.
The researchers adjusted for age, sex, high blood pressure, and cardiovascular disease, which strengthens the analysis but does not eliminate residual confounding. Self-reported food records can miss details, and participants may understate or misremember intake. The sweetener list was also incomplete, so the results cannot be generalized to every product on the market.
What remains most useful is the specificity of the signal. The study did not simply suggest that all sugar substitutes are equal or that every older adult is at risk. It found a stronger association in middle age, a larger signal in diabetes, and a concentration of risk across six named sweeteners. Those details will matter when future studies try to separate product-by-product effects from broader dietary pattern effects.
The next step is not speculation but confirmation. Longer follow-up, more precise exposure measurement, and mechanistic work will be needed to determine whether these compounds contribute directly to cognitive decline, and whether some alternatives are meaningfully safer than others.